Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 30;25(15):8301.
doi: 10.3390/ijms25158301.

The Role of Viruses in the Pathogenesis of Immune-Mediated Gastro-Intestinal Diseases

Affiliations
Review

The Role of Viruses in the Pathogenesis of Immune-Mediated Gastro-Intestinal Diseases

Francesca Bernardi et al. Int J Mol Sci. .

Abstract

Immune-mediated gastrointestinal (GI) diseases, including achalasia, celiac disease, and inflammatory bowel diseases, pose significant challenges in diagnosis and management due to their complex etiology and diverse clinical manifestations. While genetic predispositions and environmental factors have been extensively studied in the context of these conditions, the role of viral infections and virome dysbiosis remains a subject of growing interest. This review aims to elucidate the involvement of viral infections in the pathogenesis of immune-mediated GI diseases, focusing on achalasia and celiac disease, as well as the virome dysbiosis in IBD. Recent evidence suggests that viral pathogens, ranging from common respiratory viruses to enteroviruses and herpesviruses, may trigger or exacerbate achalasia and celiac disease by disrupting immune homeostasis in the GI tract. Furthermore, alterations in the microbiota and, specifically, in the virome composition and viral-host interactions have been implicated in perpetuating chronic intestinal inflammation in IBD. By synthesizing current knowledge on viral contributions to immune-mediated GI diseases, this review aims to provide insights into the complex interplay between viral infections, host genetics, and virome dysbiosis, shedding light on novel therapeutic strategies aimed at mitigating the burden of these debilitating conditions on patients' health and quality of life.

Keywords: Crohn’s disease; achalasia; celiac disease; inflammatory bowel disease; ulcerative colitis; virome; virus.

PubMed Disclaimer

Conflict of interest statement

F.F. has received consulting fees from Amgen, AbbVie, Janssen, and Pfizer. F.D. has served as a speaker for Sandoz, Janssen, Galapagos, and Omega Pharma; he has also served as an advisory board member for Abbvie, Ferring, Galapagos, and Nestlè. M.A. has received consulting fees from Nikkiso Europe, Mundipharma, Janssen, AbbVie, Ferring, and Pfizer. D.S. has served as a speaker, consultant, and advisory board member for Schering-Plough, AbbVie, Actelion, Alphawasserman, AstraZeneca, Cellerix, Cosmo Pharmaceuticals, Ferring, Genentech, Grunenthal, Johnson and Johnson, Millenium Takeda, MSD, Nikkiso Europe GmbH, Novo Nordisk, Nycomed, Pfizer, Pharmacosmos, UCB Pharma, and Vifor. B.F., U.F., A.Z., T.L.P., and M.L. declare no conflicts of interest.

Figures

Figure 1
Figure 1
Intestine immune response to viral infection.
Figure 2
Figure 2
Alterations in the gut virome are associated with the initiation and severity of IBDs. Virome changes impact intestinal mucosa integrity: phages indirectly stimulate the immune response by releasing bacterial products following lysis or transcytosis, which activate pattern recognition receptors on IECs or immune cells. Moreover, virome factors disrupt barrier integrity and influence intestinal physiology through interactions with commensals. Phages modify host bacterial dynamics, leading to dysbiosis and contributing to IBD pathogenesis. Furthermore, phages shape immunity, prompting type-I interferon responses in immune cells, thereby exacerbating intestinal inflammation and disease severity.

Similar articles

Cited by

  • Focus on Achalasia in the Omics Era.
    Di Brina ALP, Palmieri O, Cannarozzi AL, Tavano F, Guerra M, Bossa F, Gentile M, Merla A, Biscaglia G, Cuttitta A, Perri F, Latiano A. Di Brina ALP, et al. Int J Mol Sci. 2024 Sep 21;25(18):10148. doi: 10.3390/ijms251810148. Int J Mol Sci. 2024. PMID: 39337632 Free PMC article. Review.
  • Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases.
    Calvez V, Puca P, Di Vincenzo F, Del Gaudio A, Bartocci B, Murgiano M, Iaccarino J, Parand E, Napolitano D, Pugliese D, Gasbarrini A, Scaldaferri F. Calvez V, et al. Biomedicines. 2025 Jan 26;13(2):305. doi: 10.3390/biomedicines13020305. Biomedicines. 2025. PMID: 40002718 Free PMC article. Review.
  • Unraveling the microbial mysteries: gut microbiota's role in ulcerative colitis.
    Ren K, Yong C, Jin Y, Rong S, Xue K, Cao B, Wei H. Ren K, et al. Front Nutr. 2025 Feb 10;12:1519974. doi: 10.3389/fnut.2025.1519974. eCollection 2025. Front Nutr. 2025. PMID: 39996003 Free PMC article. Review.

References

    1. Abraham C., Cho J.H. Inflammatory Bowel Disease. N. Engl. J. Med. 2009;361:2066–2078. doi: 10.1056/NEJMra0804647. - DOI - PMC - PubMed
    1. Wu X.Y., Liu Z.Q., Wang Y., Chen W.F., Gao P.T., Li Q.L., Zhou P.H. The Etiology of Achalasia: An Immune-Dominant Disease. J. Dig. Dis. 2021;22:126–135. doi: 10.1111/1751-2980.12973. - DOI - PubMed
    1. Pozo-Rubio T., Olivares M., Nova E., De Palma G., Mujico J.R., Ferrer M.D., Marcos A., Sanz Y. Immune Development and Intestinal Microbiota in Celiac Disease. Clin. Dev. Immunol. 2012;2012:654143. doi: 10.1155/2012/654143. - DOI - PMC - PubMed
    1. Ates F., Vaezi M.F. The Pathogenesis and Management of Achalasia: Current Status and Future Directions. Gut Liver. 2015;9:449–463. doi: 10.5009/gnl14446. - DOI - PMC - PubMed
    1. Furuta G.T., Katzka D.A. Eosinophilic Esophagitis. N. Engl. J. Med. 2015;373:1640–1648. doi: 10.1056/NEJMra1502863. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources